Skip to main content

FBT · First Trust NYSE Arca Biotechnology Index Fund ETF

First Trust Exchange-Traded Fund

SEC fund profile
$270.93 -1.04% At close · Sep 4
Net assets $2,812,691,023
Holdings32
1 month
+5.86%
Year to date
+31.19%
52-week range
$173.98–$274.99
30-session avg volume
54,665

Market performance

Adjusted close · up to five years

Since Sep 2021

Fund profile

Structure
Open-end / ETF
SEC series
S000012478
Report date
Jun 30, 2026
Holdings coverage
Full reported portfolio

Portfolio concentration

Top 10 holdings43.20%

Calculated only when the SEC filing is stored with complete portfolio coverage.

Asset allocation

EC100.01%
STIV0.05%
RA0.00%

Country allocation

US84.96%
IE4.24%
NL3.13%
DE2.63%
DK2.62%
CH2.48%

Portfolio holdings

Latest linked SEC Form NPORT-P report.

Export CSV
HoldingValueWeight
CORCEPT THERAPEUTICS INC$157,460,9725.60%
NEOGENOMICS INC$143,995,9475.12%
VERACYTE INC$143,370,7955.10%
BRUKER CORP$121,506,8504.32%
ALKERMES PLC$119,202,5024.24%
ILLUMINA INC$110,351,7873.92%
KRYSTAL BIOTECH INC$108,912,6903.87%
NATERA INC$106,730,0683.79%
AXSOME THERAPEUTICS INC$104,301,8823.71%
NEUROCRINE BIOSCIENCES INC$99,241,3293.53%
BIO-TECHNE CORP$96,544,4973.43%
ARROWHEAD PHARMACEUTICALS INC$94,969,5023.38%
BIOGEN INC$94,803,6713.37%
EXELIXIS INC$93,280,5043.32%
INCYTE CORP$89,555,8743.18%
ARGENX SE$88,057,4343.13%
HALOZYME THERAPEUTICS INC$87,590,8613.11%
VERTEX PHARMACEUTICALS INC$86,415,1253.07%
REPLIGEN CORP$86,222,3033.07%
BIOMARIN PHARMACEUTICAL INC$79,640,5132.83%
AMGEN INC$78,300,1212.78%
BIONTECH SE$73,949,3472.63%
GENMAB A/S$73,800,9022.62%
UNITED THERAPEUTICS CORP$71,926,8492.56%
ALNYLAM PHARMACEUTICALS INC$70,923,2702.52%
BEONE MEDICINES LTD$69,844,7222.48%
GILEAD SCIENCES INC$68,968,8802.45%
ADMA BIOLOGICS INC$65,483,2562.33%
SAREPTA THERAPEUTICS INC$64,393,6982.29%
REGENERON PHARMACEUTICALS INC$63,195,7792.25%
DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS$1,526,3910.05%
DAIWA CAPITAL MARKETS AMERICA INC.$4,6890.00%